Screener
Maravai LifeSciences Holdings, Inc. MRVI Total Equity
Total Equity at other companies
Other financials
Where this comes from
Reported directly by Maravai LifeSciences Holdings, Inc. in its filing.
Tagged under the XBRL concept us-gaap:StockholdersEquity.
The source filing: Maravai LifeSciences Holdings, Inc.’s 10-Q, filed August 7, 2026. Open the filing →
- Filed
- Aug 7, 2026, 4:03 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001823239-26-000059
FAQ
- What is Maravai LifeSciences Holdings, Inc.'s total equity?
- Maravai LifeSciences Holdings, Inc. (MRVI) reported total equity of $204.62M in Q2 2026.
- How has Maravai LifeSciences Holdings, Inc.'s total equity changed year-over-year?
- Maravai LifeSciences Holdings, Inc.'s total equity decreased by 23.0% year-over-year, from $265.86M to $204.62M.
- What is the long-term trend for Maravai LifeSciences Holdings, Inc.'s total equity?
- Over 5 years (2020 to 2025), Maravai LifeSciences Holdings, Inc.'s total equity has grown at a 19.1% compound annual growth rate (CAGR), from $88.51M to $212.38M.
- What does total equity mean?
- Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.
Ask your AI about Maravai LifeSciences Holdings, Inc.'s total equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude